focus -WSS

focus

author：Wikipedia 2025-09-30 17:45:41 - browse：68837

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Merck drug for rare lung condition set for approval in U.S.

Wikipedia

focus

WSS

Readout Newsletter: Merck, Vertex, and Viking updates

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Intellia reports positive results for its CRISPR

The Readout: Lenmeldy, GLP

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Steward Health Care has deal to sell doctor network to UnitedHealth

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

With trial win, GSK could get blood cancer drug back on market

Moonlake's readout produced a cash windfall. Risks remain

States should stop sabotaging methadone treatment reform

Guidelines to prevent youth baseball injuries need more muscle

Primary care physicians play key roles in Alzheimer's management

Cancer drug shortages should be causing more outrage

Abortion pill case raises question: who can sue the FDA?

Duchenne breakthrough therapy leaves behind pioneering families

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

hotspot

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

With trial win, GSK could get blood cancer drug back on market

At ASCO, AstraZeneca reports strong data for breast cancer drug

See how much Covid

HIV drugs protect against transmission, even in unprotected sex

Abortion pill Supreme Court ruling could impact entire drug industry

Wikipedia

hotspot

focus

hotspot